Enemas de factor de crecimiento epidérmico para inducir la remisión de la colitis ulcerosa izquierda

Nodarse-Cuní, Hugo; Más-Paez, Antonio; Gutierrez-Pérez, Yoan; Valenzuela-Silva, Carmen María; Lazo-Diago, Odalys Caridad; Gutierrez-Alvarez, Carlos; Zambrano-Pérez, Georgina; Barbón-García, Anabel; Hortensia Bermúdez-Badell, Cimara; Melo-Suárez, Grettel; Periles-Gordillo, Ulises; Palomino-Besada, Amada; Páez-Meireles, Rolando; Berlanga-Acosta, Jorge; López-Saura, Pedro.
Rev. cuba. farm ; 47(1): 67-76, Jan.-Mar. 2013.
Artículo en Inglés | CUMED | ID: cum-53172

Documentos relacionados

  1. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.
  2. Chitosan-microencapsulated rhEGF in promoting wound healing.
  3. The use of epidermal growth factor in dermatological practice.
  4. Intralesional epidermal growth factor therapy in recalcitrant diabetic foot ulcers.
  5. The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis.
  6. Sodium hyaluronate combined with rhEGF contributes to alleviate clinical symptoms and Inflammation in patients with Xerophthalmia after cataract surgery.
  7. Modeling Endoscopic Improvement after Induction Treatment With Mesalamine in Patients With Mild-to-Moderate Ulcerative Colitis.
  8. Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis.
  9. Development and validation of a nomogram to predict non-response to 5-aminosalicylic acid in patients with ulcerative colitis.
  10. Evaluating the impact of recombinant human epidermal growth factor on scar formation in oral and maxillofacial traumatic wound healing.